Detalhe da pesquisa
1.
IRGM is a novel regulator of PD-L1 via promoting S6K1-mediated phosphorylation of YBX1 in hepatocellular carcinoma.
Cancer Lett
; 581: 216495, 2024 01 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-37993085
2.
A novel immunogenic cell death-related genes signature for predicting prognosis, immune landscape and immunotherapy effect in hepatocellular carcinoma.
J Cancer Res Clin Oncol
; 149(18): 16261-16277, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-37698679
3.
N6 -methyladenosine-modified circSTX6 promotes hepatocellular carcinoma progression by regulating the HNRNPD/ATF3 axis and encoding a 144 amino acid polypeptide.
Clin Transl Med
; 13(10): e1451, 2023 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37877357
4.
Nanosecond pulsed electric field stimulates CD103+ DC accumulation in tumor microenvironment via NK-CD103+ DC crosstalk.
Cancer Lett
; : 216514, 2023 Nov 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-38036040
5.
Activation of YAP1 by N6-Methyladenosine-Modified circCPSF6 Drives Malignancy in Hepatocellular Carcinoma.
Cancer Res
; 82(4): 599-614, 2022 02 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-34916222
6.
Apolipoprotein B Is Associated With the Microenvironment of Cholangiocarcinoma.
Front Oncol
; 11: 654689, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-33954113